Scleroderma can harm the lungs and kidneys.

Scleroderma can harm the lungs and kidneys.

What is Scleroderma?

Chronic autoimmune condition scleroderma (systemic sclerosis) causes excess collagen formation by attacking connective tissues. This rare inflammatory condition hardens skin and can harm the lungs, kidneys, and heart. It is most common in women aged 30–50 and has no cure. Treatments manage symptoms and delay progression.

Scleroderma

Types:

  • Localised (morphea, linear) scleroderma primarily affects the skin and underlying tissues.
  • Systemic sclerosis affects the skin, blood vessels, and organs. Subtypes:
  • Limited cutaneous (CREST syndrome)—gradual onset, fingers, hands, and face.
  • Fast-onset, extensive skin thickening, and increased risk of organ damage.
  • Sine sclerosis—organ involvement without skin thickening.

Symptoms

  • Skin: Tightness, shine, waxy areas, telangiectasia.
  • In cold, Raynaud's phenomenon causes the fingers/toes to turn white or blue.
  • Bloating, diarrhea, constipation, heartburn, and difficulty swallowing may also occur.
  • Shortness of breath, pulmonary fibrosis, and hypertension may also occur.
  • There is a risk of scleroderma renal crisis, which can lead to high blood pressure and kidney failure.
  • Heart: Arrhythmias, failure, pericarditis.
  • Joint/Muscle pain, stiffness, and inflexibility.

Causes and Risks

  • Blood arteries are damaged by autoantibodies and T-cell abnormalities.
  • Fibroblasts overproduce collagen and scar tissue.

Risk groups:

  • Women (particularly 30–50).
  • Africans and South Asians have worse illnesses.
  • Vinyl chloride, epoxy resins, and aromatic hydrocarbons may cause it.
  • Hormones and genetics may contribute.

Diagnosis 

  • Tests for diagnosis include blood tests for autoantibodies (ANA, anti-centromere, anti-Scl-70).
  • CT, echocardiogram, and chest X-ray for lung/heart involvement.
  • Biopsy: Tissue or skin.
  • Lung function tests: Damage assessment.

Management & Treatment

  • No cure—symptom control and progressive slowing.
  • Medications:
  • Methotrexate and mycophenolate are immunosuppressants.
  • Vasodilators for Raynaud's.
  • Renal crises: ACE inhibitors.
  • Proton pump inhibitors for reflux.
  • Phototherapy, physical therapy, and stem cell transplant in severe cases.
  • Lifestyle: Stay warm, hydrate, exercise lightly, and control stress.
Complications

Complications major

  • Skin, Vascular
  • In difficult situations, Raynaud's can produce fingertip ulcers, pits, or tissue death.
  • Digital ulcers and ischemia—pain, gangrene risk.
  • Calcinosis—calcium deposits under the skin, posing an infection risk.
  • Telangiectasia—dilated vessels cause red face/hands.

Lung involvement

  • Interstitial lung disease (ILD)—scarring limits breathing.
  • High lung artery pressure causes cardiac strain in pulmonary hypertension (PAH).
  • Reduced exercise tolerance, shortness of breath due to progressive fibrosis.

Problems with the kidneys

  • Rapid kidney failure and severe hypertension in scleroderma renal crisis.
  • Must take ACE inhibitors immediately to avoid irreparable harm.

Problems with the heart

  • Arrhythmias are irregular heartbeats.
  • Scarred cardiac tissue causes heart failure.
  • Inflammation of the heart sac—pericarditis.

The Digestion System

  • Reflux, swallowing problems.
  • Bowel issues—bloating, diarrhea, constipation, malabsorption.
  • Anaemia, stomach bleeding from GAVE.

Dental, Joint Issues

  • High decay, tight facial skin, tiny mouth opening, and poor oral care.
  • Finger contractures resulted from joint rigidity.

Urgent Care Red Flags

  • Raynaud's with fingertip ulcers worsening quickly.
  • Unexpected hypertension or renal failure.
  • Declining lung function causes breathlessness.
  • An irregular heartbeat or chest discomfort.
  • Undiagnosed anaemia or GI haemorrhage. 

Scleroderma complication screenings

Scleroderma problems can be quiet, so doctors utilize screening tests to detect them early. Monitoring targets skin, vascular, lung, heart, kidney, and gastrointestinal systems.

Important Screening Tests

  • Skin, Vascular
  • Nailfold capillaroscopy—checks microscopic blood arteries for early injury.
  • Assessing digital ulcers for ischemia and tissue loss.

lung involvement

  • PFTs assess lung capacity and gas exchange.
  • HRCT—detects interstitial lung disease (fibrosis).
  • Echocardiogram—pulmonary hypertension screening.

Kidney Watching

  • A frequent blood pressure assessment can detect renal crisis early.
  • Test kidney function with serum creatinine and urinalysis.

Heart Screening

  • ECG identifies arrhythmias.
  • The echocardiogram measures heart function and pulmonary pressure.
  • Detailed cardiac MRI for fibrosis or inflammation.

The Digestion System

  • Checks for reflux or stomach vascular ectasia with endoscopy.
  • Barium swallow—esophageal motility analysis.
  • Tests for anemia following GI hemorrhage.

Scleroderma complication prevention

Scleroderma problems are prevented by early discovery, lifestyle changes, and organ-specific monitoring. To prevent life-threatening complications, Indian rheumatologists recommend lung and kidney screening, blood pressure control, and Raynaud's management. 

Main Prevention Methods

  • Skin, Vascular
  • Wear gloves and warm clothes to avoid Raynaud's attacks.
  • Stay away from smoking—it damages arteries.
  • Regular wound care avoids digital ulcers and infections.
  • Low-dose aspirin—may lower clot risk.

Lung protection

  • Annual PFTs and HRCTs are recommended for early detection of fibrosis.
  • Early reflux treatment minimizes aspiration and lung scarring.
  • Influenza and pneumococcal immunizations prevent illnesses.

Kidney Watching

  • Daily blood pressure checks—early renal crisis detection.
  • Treat hypertension with ACE inhibitors immediately.
  • Avoid high-dose steroids—renal crisis risk.

Heart Care

  • Annual echocardiogram—pulmonary hypertension and fibrosis screenings.
  • ECG monitoring—early arrhythmia detection.
  • Gentle aerobic exercise promotes circulation.

The Digestion System

  • PPIs prevent reflux issues.
  • Small, frequent meals decrease reflux and bloating.
  • Supplement iron and vitamins to prevent GI bleeding anemia.

Risks and Factors

  • Delayed irreversible lung/kidney screening.
  • Steroid abuse raises renal crisis risk.
  • Poor adherence worsens results; patient education matters.
The video about New Hope for Systemic Sclerosis


Systemic sclerosis treatments

Treating scleroderma involves managing fibrosis, vascular problems, and immunological activation. The latest worldwide guidelines (EULAR 2023) prescribe methotrexate, mycophenolate, rituximab, tocilizumab, and nintedanib for lung involvement. Although biologics are expensive, tertiary rheumatology institutes in India offer them. 

Main Treatment Methods

  • Skin Fibrosis
  • Methotrexate—first-line for early-progressing cutaneous illness.
  • Mycophenolate mofetil (MMF) treats skin and pulmonary fibrosis.
  • Rituximab depletes B-cells, beneficial in refractory patients.
  • Tocilizumab, an IL-6 blocker, may be effective for treating diffuse cutaneous illness.
  • Localized skin thickening can be treated with UVA-1 phototherapy.

Interstitial lung disease

  • Recommended first-line mycophenolate mofetil.
  • An alternative for severe ILD: cyclophosphamide.
  • Nintedanib slows lung fibrosis progression.
  • Biologicals under trial for Rituximab/Tocilizumab show promise.

Vascular Issues

  • For Raynaud's phenomenon, consider calcium channel blockers (amlodipine, nifedipine), PDE-5 inhibitors, and prostacyclin analogues.
  • Infusions of bosentan and iloprost for digital ulcers.
  • Combination therapy for pulmonary arterial hypertension (PAH) includes endothelin antagonists, PDE-5 inhibitors, and prostacyclin analogues.
  • In acute renal crisis, ACE inhibitors (captopril, enalapril) are essential lifesaving treatments.

GI Symptoms

  • For reflux and esophageal involvement, use proton pump inhibitors.
  • Prokinetics for motility issues.
  • In severe GI disease, nutrition is crucial.

Risks and Factors

  • Immunosuppressants increase infection risk.
  • Costly biologics (rituximab, tocilizumab) necessitate hospital supervision.
  • Nintedanib may raise liver enzymes and cause diarrhea.
  • Cyclophosphamide can cause bladder toxicity and infertility.
  • AIIMS, CMC Vellore, and major rheumatology facilities in India offer biologics, which may require insurance or government programs.

Conclusion

Modern immunosuppressants, biologics, antifibrotics, and organ-specific therapy can improve outcomes, but there is no cure. Risk reduction requires screening, blood pressure monitoring, immunizations, and lifestyle changes.

Sudden hypertension, worsening Raynaud's, or inexplicable dyspnea must be detected early. Multidisciplinary treatment and proactive management can preserve quality of life and prevent irreversible damage.

Yersinia pestis, a deadly disease, must be treated immediately.

Yersinia pestis, a deadly disease, must be treated immediately.

What is Yersinia pestis?

Plague, caused by Yersinia pestis, is rare but deadly. The “Black Death” still kills 1,000–2,000 people annually, predominantly in Africa and Asia. Rapid antibiotic therapy works well. Bacteria that cause plague are Gram-negative. Rats, mice, squirrels, prairie dogs, chipmunks, and rabbits.

Yersinia pestis
Yersinia pestis-infected

Transmission:

  • Infected fleas (Xenopsylla species) bite.
  • Infected animal tissue/blood contact.
  • Human/animal droplets inhaled (pneumonic plague).
  • Infected domestic cat scratches/bites.
  • "Plague" is the common name for Yersinia pestis.

Bubonic plague, 

  • The most common type is characterised by enlarged lymph nodes (buboes).
  • Septicemic plague can cause bleeding and shock.
  • The most dangerous and contagious is pneumonic plague.
  • The 14th-century pandemic known as the Black Death killed millions in Europe.

Types of Plague

Bubonic plague:

  • It is very prevalent, accounting for approximately 80% of cases.
  • Swollen lymph nodes (“buboes”), fever, chills, and weakness.
  • Without treatment, septicemia can occur.

Septicemic plague:

  • Bloodstream bacteria spread.
  • The symptoms are abdominal pain, vomiting, skin bleeding, and shock.
  • Without antibiotics, mortality is high.

Airborne plague:

  • Lung infection.
  • Fever, chest discomfort, bloody cough, and severe breathing trouble.
  • Person-to-person transmission is most harmful.

What are the symptoms of Yersinia pestis?

Bubonic, septicemic, and pneumonic Yersinia pestis (plague) symptoms vary. Bubonic plague causes painful, enlarged lymph nodes (buboes), septicemic plague causes hemorrhage and shock, and pneumonic plague causes severe pneumonia with cough and chest pain. Without quick treatment, all types are fatal.

Plague symptoms

  • Swollen lymph nodes (buboes) at the flea bite site: painful, red, and tender.
  • After exposure, fever and chills begin 2–6 days later.
  • Headaches, muscle pain, and weakness.
  • Cases that go untreated may spread to the bloodstream, resulting in septicemic plague.

Septic Plague Signs

  • Nausea, vomiting, diarrhea, and abdominal pain are symptoms of a bloodstream infection.
  • Blood problems: abrupt bruises, bleeding under the skin, blood in urine, and mouth/nose/rectum bleeding.
  • Shock symptoms: low blood pressure, fast pulse, unconsciousness.
  • Untreated complications: kidney failure, severe respiratory problems, and death.

Pneumonia symptoms

  • Lung infection: high fever, chills, headache, chest pain.
  • Rapid breathing, severe shortness of breath.
  • Bloody cough, watery sputum.
  • A droplet-based transmission risk.
  • Untreated, the most serious kind can kill within days.

Important Notes

  • Incubation: 1–8 days, form-dependent.
  • Untreated plague can be lethal, although antibiotics can reduce bubonic plague mortality to <10%.

Yersinia pestis diagnosis

Clinical suspicion and exposure history are used to diagnose Yersinia pestis (plague), followed by laboratory confirmation utilizing blood, lymph node aspirates, or sputum cultures. If a plague is suspected, treat promptly without waiting for test results.

Clinical Suspicion

  • Plague is considered by doctors when:
  • Bug bites or rodent exposure.
  • Visit endemic regions (Africa, Asia, and the western U.S.).
  • Contact with dead or diseased animals (particularly cats or rodents).
  • An acute fever, buboes, or pneumonia.

Laboratory Verification

  • Lymph node aspirate: Microscopically and culturally analysed bulges include various species.
  • Septicemic plague blood cultures: Detect bacteremia.
  • Pneumonic plague sputum culture.

Microscopy: 

  • Gram or Wright/Giemsa stains exhibit Y. pestis' "safety pin" look.
  • If cultures are negative, acute and convalescent serum samples confirm infection.
  • More people use PCR/rapid antigen tests for speedier detection.

Clinical Guidelines

  • If plague is suspected, start antibiotics immediately.
  • Public health officials must be notified of plague.
  • Pneumonic plague patients must isolate droplets to prevent dissemination.
  • Other infections, including yersiniosis, tularemia, and severe pneumonia, can mimic plague.

Prevention of Yersinia pestis

Yersinia pestis (plague) prevention involves managing rodents and fleas, avoiding contact with diseased animals, and protecting patients' close contacts. As plague is zoonotic, environmental and personal measures are crucial.

Important Prevention Methods

Rodent control:

  • Cleaning up rubbish, woodpiles, and food sources around dwellings reduces rodent habitats.
  • Do not handle dead rats or wildlife.

Flea control:

  • Use DEET-based bug repellents when camping or hiking.
  • Treat cats and dogs with flea-control solutions.

Protective measures:

  • Protect your hands when handling diseased animals.
  • Do not touch sick cats—they can spread plague.

Public health monitoring:

  • Report unexpected rodent deaths to authorities.
  • Monitor endemic areas for outbreaks.

After-exposure protection:

  • Doxycycline or ciprofloxacin can be given to close contacts of patients with pneumonic plague for 7 days.
The video explains how to stop Yersinia pestis with medicine


Treatment for Yersinia pestis

  • Hospitalisation and intravenous antibiotics are needed for Yersinia pestis (plague). Quick treatment reduces mortality from 60% to 10%. For containment, Indian health officials must report suspicious instances.
  • In hospital care, staff isolate patients in private rooms and use gloves, masks, and protective clothes.
  • Severe bleeding, respiratory problems, or septic shock require intensive care.
  • The CDC and WHO receive instances in the U.S., while local/state health offices in India must be alerted.

Antibiotic Treatment

  • Initial agents:
  • Gentamicin
  • Streptomycin
  • Doxycycline
  • Ciprofloxacin
  • Levofloxacin, Moxifloxacin, Chloramphenicol (patient-specific options)
  • Usually 10–14 days, longer if fever or problems continue.
  • IV for severe instances, oral for stable patients.

Supportive Measures

  • IV fluids for hydration and blood pressure.
  • For respiratory discomfort from pneumonic plague, oxygen treatment.
  • Continuous monitoring of vital signs, kidney function, and coagulation.

Post-exposure Protective

  • Recommended for pneumonic plague patients' close contacts or tissue exposure.
  • Doxycycline, Ciprofloxacin, or Levofloxacin for 7 days.
  • No vaccine: Investigational vaccinations are only available to high-risk groups (lab personnel, military).

Infected fleas on rodents spread plague, a lethal zoonotic infection caused by the Yersinia pestis bacteria. Plague can also be transmitted by touching contaminated animals or inhaling respiratory droplets from victims.

Primary Infection Causes

  • Most common: flea bites. Humans get the bacteria from fleas that feed on infected rats, squirrels, and prairie dogs.
  • Wild rodents are natural hosts; outbreaks often follow die-offs.
  • Skinning rabbits or rodents exposes you to contaminated animal tissues and fluids.
  • Pneumonic plague is very contagious via respiratory droplets.
  • Rodents can infect domestic cats and spread plague to humans through bites, scratches, or respiratory droplets.

Possible Risks

  • Living in endemic regions (Africa, Asia, and the western U.S.).
  • Hunting, veterinary, farming, and outdoor labour in rodent-rich areas.
  • Travel to plague-prone areas recently.
  • Poor sanitation and rodents are common in remote areas.

Conclusion

The plague is caused by Yersinia pestis, a rare and treatable bacterium. It is spread by flea bites from infected rodents, direct contact with animals, or pneumonic plague droplet inhalation. Plague, which caused the Black Death, is now rare yet deadly. It can be managed with modern medicine and public health awareness.


Sigmoidoscopy is an efficient diagnostic procedure.

 Sigmoidoscopy is an efficient diagnostic procedure.

A sigmoidoscopy: what is it?

Sigmoidoscopy is a fast, minimally invasive procedure that uses a flexible tube equipped with a light and a camera to inspect the rectum and the sigmoid colon, the lower portion of the colon. It often takes less than 15 minutes without an anaesthetic and aids in the detection of polyps, inflammation, ulcers, and early indicators of colorectal cancer.

sigmoidoscopy

What Sigmoidoscopy Involves

  • A sigmoidoscope is a thin, flexible tube fitted with a camera and a light.
  • Procedure: Inserted through the anus and guided into the sigmoid colon and rectal cavity. 
  • To improve visibility, the colon may be expanded by adding air.
  • The procedure usually lasts between five and fifteen minutes.
  • Comfort: There is often no sedation, though there may be slight gas or cramps.

Why Has It Been Completed?

  • Blood in the stool or rectal bleeding
  • Constipation, diarrhea, or abdominal pain
  • Suspected growths or polyps
  • Crohn's disease and ulcerative colitis are examples of inflammatory bowel diseases.
  • Colorectal cancer screening (particularly in cases when colonoscopy is not readily available)

Colonoscopy vs. Sigmoidoscopy

  • Examined Test Area Required Sedation Prep Time
  • Rectum and sigmoid colon sigmoidoscopy. No sedation: 5–15 minutes of enema
  • colonoscopy of the whole colon. Sedation is necessary, and full bowel preparation takes 20 to 30 minutes.

Hazards and Recuperation

  • Gas, moderate cramps, and minor bleeding (particularly following a biopsy) are minor concerns.
  • Rare hazards include prolonged bleeding, infection, and colon wall perforation.
  • Recuperation: Gas discomfort normally goes away in a few hours; normal diet and activities continue the same day.

Steps to prepare for sigmoidoscopy

While getting ready for a sigmoidoscopy is less complicated than for a colonoscopy, there are still some crucial preparations that must be taken to guarantee that the rectum and sigmoid colon are clearly visible.

01. 

Adhere to dietary guidelines.

To lessen stool in the lower intestine, your doctor might suggest a light meal or clear liquids the day before.

02.

Use the recommended bowel preparation.

To clear the rectum and sigmoid colon, one or two enemas are usually administered a few hours before the test.

03. 

Modify prescriptions as necessary.

Temporary adjustments to blood thinners, diabetic medications, or iron supplements may be necessary, but only under medical supervision.

04.

Make travel arrangements.

Sedation is rarely used for comfort and support; some patients would rather be accompanied.

05.

Get there early to check in.

Bring insurance information and medical records, and be prepared to talk to the medical staff about any symptoms or family history.

The video explains the sigmoidoscopy procedure


Steps in the sigmoidoscopy process

To help you understand exactly what happens during the exam, below is a detailed explanation of the steps involved in the sigmoidoscopy procedure:

Methodical Procedure

  • Arrival and Consent
  • You will be required to sign a consent form and provide information about your medical history.
  • Before beginning, vital signs may be taken.

Placing

  • In the "left lateral" position, you lie on your left side with your knees bent.
  • This makes the rectum and sigmoid colon easily accessible.

Scope Insertion

  • A flexible, lubricated sigmoidoscope is carefully passed via the anus.
  • To make the colon more visible, air or carbon dioxide can be added.

Examination

  • The doctor examines the sigmoid colon and rectum on a video monitor.
  • It is possible to detect bleeding spots, ulcers, polyps, and inflammation.

Polyp removal or biopsy

  • A biopsy can be performed using tiny instruments if aberrant tissue is observed.
  • During the process, polyps might be removed.

Finalization

  • While reexamining the lining, the scope is gradually removed.
  • Typically, the complete procedure takes five to fifteen minutes.

Recuperation

  • Usually, no anaesthesia is needed, so you can immediately return to your regular activities.
  • Gas or mild cramps may happen, but they generally go away fast.
  • Recovery procedures for sigmoidoscopy

What usually occurs following a sigmoidoscopy and how recovery is handled are as follows:

Steps for Immediate Recovery

  • Observation: While the staff looks for bleeding, cramps, or dizziness, you will takbriefle break.
  • Gas relief: Because air is introduced during the test, passing gas is frequently the result.
  • No sedation: You can typically return home immediately because sedation is rarely utilised.

Food and Exercise

  • Return to a regular diet: Most people can eat and drink as usual right away.
  • Return to activities: You can resume your daily routines, work, and exercise on the same day.
  • Hydration: Consuming liquids might ease moderate cramps or bloating.
When to Get Medical Assistance
  • More than a few drops of blood in the stool indicate persistent bleeding.
  • Severe stomach pain may be a sign of uncommon problems, such as a perforation.
  • Chills or fever: These could indicate an infection.
  • Side effects of sigmoidoscopy

Although moderate side effects, including cramps, bloating, and light bleeding, are typical, sigmoidoscopy is generally safe. Although uncommon, perforation of the colon wall, severe stomach discomfort, or ongoing bleeding are dangerous concerns that require immediate treatment.

Typical Adverse Reactions

  • Mild cramping: The test's introduction of air causes momentary discomfort.
  • Colon inflammation is the cause of bloating and gas, which often goes away in a few hours.
  • Light bleeding: Usually ceases in 24 to 48 hours, especially if a biopsy or polyp ectomy was done.

Uncommon yet Dangerous Risks

  • A tear in the colon wall that necessitates immediate medical attention is called a colon perforation.
  • Severe stomach pain could be a sign of issues rather than merely gas cramps.
  • Heavy or persistent bleeding: It is abnormal to have more than a few teaspoons of blood.
  • Infection: Peritonitis or other infections may be indicated by fever, chills, or edema.

Monitoring and Aftercare

  • Gas relief: Walking eases discomfort and allows air to be expelled.
  • Diet: You can start eating and drinking normally right away.
  • Activity: The majority of patients resume their regular activities on the same day.
  • Medical attention: If you have a fever, severe discomfort, vomiting, or significant bleeding, get medical care.

A Brief Comparison of Concerning and Normal Symptoms

  • Normal Concerning Symptom
  • Cramping: mild, transient, severe, and ongoing
  • bleeding, mild spotting, or moderate spotting that persists for more than 48 hours
  • Gas and bloating are common and go away fast. Large or firm abdomen
  • Normal temperature, fever, or chills

Does sigmoidoscopy cause pain?

Instead of being unpleasant, most people find sigmoidoscopy to be merely somewhat uncomfortable. You may feel cramping or pressure when the scope is inserted, and air is used to widen the colon, as anaesthesia is usually not used.

Common Feelings

  • Mild cramping: brief, like gas pains.
  • Air inflation is the cause of bloating, which normally goes away fast.
  • As the scope passes through the rectum and sigmoid colon, pressure or fullness is felt.

When Pain Is a Concern

  • Sharp abdominal pain: This could be a sign of a perforation or other problem.
  • Heavy or persistent bleeding: Spots that are more than light are abnormal.
  • Chills or fever: These could indicate an infection.

Conclusion:

Examining the rectum and sigmoid colon, sigmoidoscopy is a quick, safe, and efficient diagnostic procedure. Although there may be slight cramps, bloating, or light bleeding, it is usually comfortable. Most people return to their regular activities the same day, recovery is quick, and preparation is easy (typically simply enemas). It only covers a portion of the colon, but it helps identify polyps, inflammation, and early indicators of colorectal cancer. A colonoscopy is necessary for a thorough assessment if anomalies are discovered.

Sigmoidoscopy can be a helpful first-line test for rectal bleeding or bowel abnormalities in areas where the incidence of colorectal cancer is increasing among younger individuals. It does not, however, take the place of colonoscopy, which is still the gold standard for comprehensive screening for colorectal cancer. If the sigmoidoscopy reveals abnormalities, a colonoscopy is necessary for a thorough assessment.


Management of esophageal cancer

Management of esophageal cancer

Esophageal cancer—Outline

Esophageal carcinoma that spreads from the lining. In this dangerous disease, abnormal cells form in the esophagus, which conducts food and drink from the throat to the stomach. Anywhere in the esophagus is squamous cell carcinoma, and the lower region near the stomach can have adenocarcinoma.

Esophagus cancer
Esophagus cancer

Types:

  • Common worldwide, squamous cell carcinoma begins in flat esophageal cells.
  • Adenocarcinoma starts in glandular cells in the lower esophagus and is frequent in Western countries.
  • Sarcoma, lymphoma, melanoma, and small cell carcinoma are infrequent.

Symptoms

  • Swallowing problems (the most prevalent early indication)
  • Burning or discomfort in the chest
  • Unintentional weight loss
  • Constant indigestion or heartburn
  • Hoarseness or cough
  • Bloody vomit or cough

Causes and Risks

  • Consuming heated liquids, smoking, and drinking alcohol.
  • Chronic acid reflux, Barrett's esophagus, and achalasia.
  • Obesity, low fruit/vegetable intake.
  • HPV and chest/abdomen radiation are further dangers.

Diagnostics: 

  • Endoscopy with biopsy (gold standard).
  • CT, barium swallow, and endoscopic ultrasound.
  • Staging: Assesses tumour size, lymph node, and organ dissemination.

Treatment Choices

  • Surgical removal of the esophagus.
  • Endoscopic procedures: EMR, ESD, tiny tumour laser therapy.
  • Radiation before/after surgery or for symptoms.
  • Radiation and chemotherapy are common.
  • Immunotherapy and targeted therapy for advanced patients.

Prognosis

  • Stage and type affect survival:
  • Localized adenocarcinoma: ~51% 5-year survival.
  • Localized squamous carcinoma: ~35% 5-year survival.
  • Advanced (far spread): <10% survival.

Preventive measures: 

  • Quit smoking and avoid alcohol.
  • Maintain a healthy weight and a fruit/vegetable diet.
  • Treat acid reflux and Barrett's esophagus medically.
  • Regular high-risk screening.

First signs of esophageal cancer?

Esophageal cancer begins slowly and may not show symptoms until it progresses. The most common early symptom is dysphagia, which can feel like food is stuck in the chest or throat. Heartburn, chest pain, unexplained weight loss, and chronic cough or hoarseness are some signs.

Esophageal cancer early symptoms

  • Swallowing problems—first solids, then liquids.
  • Food trapped — chest pain or obstruction.
  • Pain or burning in the chest—misinterpreted as heartburn.
  • Heartburn/GERD—reflux that doesn't improve with treatment.
  • Cancer metabolism or reduced food intake causes unexplained weight loss.
  • Hoarseness or chronic cough—vocal cord or airway inflammation.
  • Food vomiting, especially after meals.

Why These Signs Matter

  • Many benign illnesses like GERD, ulcers, and esophagitis share these symptoms.
  • Consult a doctor if symptoms last longer than 2–3 weeks.
  • Treatment outcomes improve greatly with early discovery.

Risk Factors That Increase the Chance

  • Drinking and smoking
  • Barrett's esophagus or chronic acid reflux
  • Low fruit/vegetable intake and obesity
  • Over 55
  • Drinking hot liquids frequently

What To Do

  • If you have trouble swallowing or chest pain, see a doctor.
  • Endoscopic biopsy is the best diagnostic method.
  • Early treatment options include endoscopic removal or surgery, depending on the stage.

Can treatment extend esophageal cancer survival?

Esophageal cancer survival rates vary by stage: localized disease has a 49% 5-year survival rate, regional spread 28%, and distant metastasis 5% during treatment. Across all stages, the average 5-year survival rate is 22%.

Stage-specific survival rates (U.S. SEER, 2015–2021).

  • Notes: Stage 5-year survival rate
  • Localized: ~49%. Esophageal cancer; surgery or endoscopic removal is feasible.
  • Regional: ~28%. Spread to neighboring lymph nodes/tissues; surgery+chemoradiation.
  • Distant Metastasis: ~5%; systemic therapy, palliative focus.
  • All stages total ~22%. Shows average survival.

Survival Factors

  • Adenocarcinoma has a slightly better outlook than squamous cell carcinoma.
  • Neoadjuvant chemoradiation followed by surgery enhances survival over chemoradiation alone.
  • Patient health: Nutrition, age, and concurrent diseases strongly impact outcomes.
  • Chemotherapy/radiation shrinks tumours, improving prognosis.
  • Early detection: Pre-spread diagnosis improves survival.

Important Considerations

  • Survival statistics are averages and do not predict individual outcomes.
  • Recent treatment improvements may help current patients outperform earlier statistics.
  • Quality of life is crucial in advanced stages.

Is esophageal cancer curable?

  • Esophageal cancer can be cured if identified early and vigorously treated.

Curability Factors

Cancer stage

  • Surgery or endoscopic removal, occasionally with radiation or chemotherapy, can cure early stages (I–II).
  • Stage III: Chemoradiation + surgery may cure.
  • Stage IV: Control and symptom alleviation; rarely curable.

Type of tumor

  • Localized adenocarcinoma: Better results.
  • Squamous cell carcinoma: Early cure, rapid spread.
  • Clear surgical margins improve cure rates.
  • Health: Younger, healthier individuals tolerate vigorous treatment better.

How to diagnose esophageal cancer?

Doctors use esophageal cancer diagnostics to directly visualize the esophagus, obtain tissue samples, and assess disease severity.

Important Diagnostic Methods

  • Endoscopic biopsy
  • Camera-equipped thin, flexible tubes are inserted into the neck.
  • Examine suspicious regions and take tissue samples.
  • The gold standard for diagnostics.
  • EUS endoscopic ultrasound
  • Uses sound waves to assess tumor invasion of the esophageal wall.
  • Assesses surrounding lymph nodes.

Imaging tests

  • CT scan: Shows chest/abdomen spread.
  • PET scan: Shows cancer cell metabolism.
  • The barium swallow X-ray involves the patient swallowing a contrast liquid to detect obstructions or narrowing.

Bronchoscopy

  • Sometimes used for airway cancer suspicion.

Post-Confirmation Stage

  • After diagnosing cancer, clinicians assess the stage by:
  • Tumour depth and size.
  • To lymph nodes.
  • Remote metastases (liver, lungs).

Methods of diagnosis

  • Upper Endoscopy (EGD): A flexible tube with a tiny camera enters the throat to observe the esophageal lining.
  • Endoscopy biopsy: Small tissue samples are examined under a microscope for cancer cells.
  • A unique scope produces close-up images of the tumour's depth in the wall using endoscopic ultrasound (EUS).
The video explains Esophageal cancer treatment options



Stage-based esophageal cancer treatment

Esophageal cancer treatment is stage-dependent. Early stages (0–I) can be treated with surgery or endoscopic removal, but advanced stages (III–IV) require chemoradiation, targeted medicines, or immunotherapy, with stage IV focused on control and quality of life.

Staged Treatments

  • Stage: Main Treatment Options Notes
  • High-grade dysplasia, stage 0. The endoscopic mucosectomy or surgery removes aberrant cells before invasion.
  • Stage I: Esophagectomy surgery or chemoradiation followed by surgery. Tumour type and patient health determine the curative goal.
  • Stage II: Chemoradiation and surgery, or surgery alone. Survivability improves with chemotherapy before surgery.
  • In Stage III, aggressive multimodal therapy may include surgery if the tumour is resectable.
  • In Stage IV, chemotherapy, immunotherapy, targeted therapy, and palliative radiation/stents are used. Prioritize symptom relief, life extension, and quality.
  • Treatment options for recurrent disease include immunotherapy (e.g., nivolumab), chemoimmunotherapy, and palliative. Many recommend clinical trials.

Additional Treatment Methods

  • Therapeutic targeting: For HER2, PD-L1-mutated cancers.
  • Immunotherapy: Advanced/metastatic checkpoint inhibitors.
  • Radiation therapy: Used before surgery to reduce tumors, after surgery to eliminate leftover cells, or alone if surgery is not possible.
  • Palliative care: Stents, lasers, and feeding tubes help with swallowing and nutrition.

Important Considerations

  • Since stage 0–I tumors are treatable, early identification is crucial.
  • For the greatest results, stage II–III demands strong multimodal therapy.
  • Stage IV is rarely treatable; survival and comfort are priorities.
  • Patient health and preferences substantially impact treatment.

Conclusion

Early stages are treated with curative surgery or endoscopic therapy, intermediate stages with chemoradiation and surgery, and advanced stages with systemic/palliative therapies.

Localized esophageal cancer patients can live for years, sometimes beyond five years, with treatment. Advanced cases have a shorter survival rate but can benefit from modern therapies that improve life and comfort.


Obsessive-compulsive disorder treatment guidelines

Obsessive-compulsive disorder treatment guidelines

Obsessive-compulsive disorder-Describe 

Obsessive-compulsive disorder (OCD) is a mental illness characterised by intrusive, upsetting thoughts (called obsessions) and repetitive actions (called compulsions) that are performed to lessen anxiety. It typically begins in infancy or early adulthood and affects about 2-3% of people worldwide. If left untreated, it can seriously disrupt everyday living.

Obsessive compulsive disorder

Important OCD Features

  • Anxiety-inducing, persistent, unwelcome thoughts, images, or urges are known as obsessions.
  • Examples include a demand for symmetry or order, intrusive violent or sexual impulses, fear of infection, and concerns about safety (such as unsecured doors).
  • Compulsions: Repeated actions or mental routines carried out to reduce tension or avert dreaded consequences.
  • Examples include counting, organising things, checking locks frequently, washing your hands excessively, and repeating prayers or mantras.

Typical Symptoms

  • Compulsions and Obsessions
  • Fear of contamination: excessive cleaning and washing
  • Uncertainties regarding safety: Regularly inspecting stoves and locks
  • Order and symmetry are necessary: Organising things till they are "just right."
  • Sexual or violent ideas that are intrusive. Mental rituals (phrases, prayers)

Causes and Risk Elements

  • Changes in the brain: Modified circuits related to movement, planning, and judgment.
  • Genetics: A strong genetic component is present, particularly in cases that begin in childhood.
  • Environmental triggers include traumatic experiences, stressful life events, and familial influences.
  • Risk factors include co-occurring mental health illnesses (such as anxiety, depression, and tic disorders), early onset (before 25), and family history.

Effects and difficulties take

  • They can take up hours every day, interfering with relationships, jobs, and school.
  • Physical injury, such as dermatitis from washing your hands, can occur.
  • There is a higher chance of suicidal thoughts, anxiety, and depression.
  • In the absence of treatment, symptoms frequently last for years.

Diagnosis

  • According to DSM-5 criteria, the existence of obsessions or compulsions that interfere with functioning, create distress, and take up more than an hour each day.
  • Measures of severity include the Yale-Brown Obsessive Compulsive Scale (Y-BOCS).

Options for Treatment

  • In particular, Exposure and Response Prevention (ERP) in cognitive behavioural therapy (CBT) allows individuals to confront triggers without engaging in compulsive behaviours.
  • Drugs: clomipramine or SSRIs (fluoxetine, sertraline, paroxetine, or fluvoxamine).
  • Combination therapy is frequently the most successful.
  • Neuromodulation (TMS, DBS) for resistant instances is an advanced option.

Complications of Obsessive-Compulsive Disorder:

Complications from obsessive-compulsive disorder (OCD) can be both psychological and physical, ranging from difficult relationships and everyday functioning to major health problems such as dermatitis, dehydration, and, in extreme situations, renal failure. Untreated OCD frequently worsens over time, increasing the risk of depression and suicide as well as causing disability.

Significant OCD Complications

1. Social and Psychological Effects

  • Rituals take up hours a day, interfering with social life, employment, and education.
  • Avoidance and compulsive habits trouble partnerships.
  • A low standard of living, along with persistent humiliation and worry, contributes to these problems.
  • In severe OCD instances, suicidal thoughts and actions are more prevalent.

2. Problems with Physical Health

  • Skin injury and dermatitis from frequent cleaning or hand washing.
  • Severe dehydration occurs when compulsions impede drinking water.
  • Fluid restriction is associated with renal impairment (injury to the kidneys).
  • Obesity or malnutrition brought on by irregular eating habits.
  • Chronic cases include high cholesterol and metabolic problems.

3. Neglecting Oneself

  • Inability to take care of oneself or maintain basic hygiene because of compulsions.
  • Ritual avoidance is frequently associated with severe episodes of urinary incontinence.
  • Medical requirements are neglected, and physical disease worsens.

4. Co-occurring Conditions

  • OCD is often accompanied by anxiety and depression.
  • Abuse of substances may emerge as a coping strategy.
  • Patients with OCD are more likely to have tic disorders and other neuropsychiatric problems.

Snapshot of Complications

  • Complication Mechanism Result
  • Washing too much can cause dermatitis. Infections and skin damage
  • Dehydration: Consistently avoiding liquids. Fatigue and renal failure
  • Eating incorrectly can lead to malnutrition and obesity. Extremes in weight and metabolic problems
  • Chronic anxiety and depressionSuicidal ideation and impairment
  • Ritual interference causes social isolation. Broken relationships and a low standard of living

Preventive measures for problems related to OCD

To lower both psychological and physical risks, preventive measures for OCD complications center on early treatment, lifestyle modifications, and continuing support.

Important Preventive Techniques

1. Prompt Diagnosis and Therapy

  • As soon as symptoms start to interfere with day-to-day activities, seek professional assistance.
  • Escalation is avoided when CBT is used early in conjunction with ERP (Exposure and Response Prevention).
  • Before problems arise, medication (SSRIs, clomipramine) can stabilise symptoms.

2. Handling Stress

  • Yoga, mindfulness meditation, and relaxation methods lessen anxiety causes.
  • Structured procedures lessen obsessive thinking spirals.
  • Frequent sleep schedules lower compulsive cravings and calm mood.

3. A healthy way of living

  • Malnutrition, dehydration, and kidney problems can be avoided with a balanced diet and adequate hydration.
  • Limit alcohol, nicotine, and caffeine as these substances exacerbate compulsive behaviours and anxiety.
  • Frequent exercise lowers compulsive tendencies and elevates mood.

4. Systems of Support

  • Family education increases treatment adherence and decreases stigma.
  • Support groups lessen loneliness and offer coping mechanisms.
  • Therapy communities promote resilience and accountability.

5. Health Monitoring

  • Examinations by dermatologists for skin damage caused by frequent bathing.
  • Routine laboratory testing for cholesterol, renal function, and hydration.
  • Psychiatric follow-ups to track suicide risk, anxiety, and depression.

Snapshot of Prevention

  • Complication-Prevented Strategy Notes
  • Severe rituals and early disability diagnosis. CBT in addition to medicine
  • Stress management: Depression and anxiety. Meditation and yoga
  • Physical illness: A healthy lifestyle. Exercise, hydration, and diet
  • Family, groups, poor adherence, loneliness, and support networks
  • Medical observation of metabolic, renal, and skin problems. Frequent examinations
The video is about a new treatment for kids with OCD



Obsessive-compulsive disorder treatment:

Psychotherapy, particularly Cognitive Behavioural Therapy (CBT) with Exposure and Response Prevention (ERP), and drugs like SSRIs or clomipramine are the most successful therapies for obsessive-compulsive disorder (OCD). Advanced methods such as neuromodulation (TMS, DBS) may be useful for resistant instances.

Methods of Psychotherapy

  • CBT, or cognitive-behavioral therapy
  • Reduces compulsive behaviors and assists patients in identifying unreasonable anxieties.
  • Prevention of Exposure and Reaction (ERP)
  • Exposure to fearful cues gradually while avoiding compulsive behaviours.
  • For instance, you might touch something "dirty" and then avoid cleaning your hands right away.
  • Reversing habits and halting thoughts: Substitute healthy reactions (such as deep breathing or saying "Stop") for compulsive behaviours.
  • Reduce family stress and offer peer support through family therapy and group therapy.

Drugs

  • SSRIs include citalopram, escitalopram, paroxetine, fluvoxamine, sertraline, and fluoxetine.
  • Tricyclic antidepressants like clomipramine are frequently useful when SSRIs don't work.
  • SNRIs: Occasionally used, such as venlafaxine.
  • Antipsychotic augmentation: olanzapine, aripiprazole, and risperidone for cases of resistance.
  • Buspirone, memantine, and ondansetron are further medicines being investigated.

Cutting-Edge & New Therapies

  • Adults with treatment-resistant OCD may benefit from transcranial magnetic stimulation (TMS), which has FDA approval.
  • Electrodes are inserted into specific brain regions during deep brain stimulation (DBS), which is only used in severe, unresponsive situations.
  • Novel treatments: Research is being done on ketamine, psilocybin, and inference-based therapy.

Self-Help & Lifestyle Techniques

  • Deep breathing, yoga, and meditation are methods for managing stress.
  • Healthy habits include eating a balanced diet, staying hydrated, exercising, and getting enough sleep.
  • Support networks include treatment communities, support groups, and family education.
  • Monitoring: Frequent examinations for mental health, kidney function, and skin problems.

Snapshot of Treatment

  • Limitations of Treatment Effectiveness
  • ERP + CBT is the gold standard for sustained relief. demands work and slow advancement
  • SSRIs have a gradual start and are effective for various side effects.
  • Clomipramine: Very effective. Additional adverse effects of antipsychotics.  Danger of metabolic problems
  • TMS/DBS: In extreme situations. restricted accessibility and intrusive

Conclusion

With a systematic approach that includes counselling, medication, and lifestyle support, OCD is very treatable. With early management, you can avoid complications, and modern therapies can treat resistant cases.

What is metabolic syndrome and how is it treated

What is metabolic syndrome, and how is it treated?

Metabolic Syndrome-Overview

Metabolic syndrome, which includes abdominal obesity, high blood pressure, high blood sugar, high triglycerides, and low HDL cholesterol, raises the risk of heart disease, stroke, and type 2 diabetes when three or more of these conditions occur. About one-third of adults globally have it.

Metabolic syndrome


Causes and Risks

  • Unresponsive cells contribute to insulin resistance and elevated blood sugar levels.
  • Obesity—especially abdominal fat.
  • Physical inactivity: Muscles use glucose less efficiently.
  • Genetics: Diabetes/hypertension in family.
  • Risk increases with age and is higher in Hispanics.

Symptoms

  • Usually silent, but may:
  • Dark spots (acanthosis nigricans).
  • Vision blurred.
  • Extreme thirst and urine.
  • Fatigue.

Complications

  • Diabetes type 2.
  • Atherosclerosis and heart disease.
  • Stroke.
  • Apnea and fatty liver.

Management and Prevention

  • Lifestyle changes:
  • Even a 7% weight loss reduces the risk of diabetes by 58%.
  • Participate in daily exercise for at least 30 minutes.
  • Mediterranean diet for heart health.
  • Quit smoking.
  • Manage stress.

Medications:

  • Cholesterol statins.
  • Antihypertensives.
  • Metformin for diabetes.
  • Bariatric surgery for severe obesity.

How to Diagnose Metabolic Syndrome?

Metabolic syndrome is diagnosed when three of the five obesity, blood pressure, blood sugar, and cholesterol criteria are met. Doctors verify it with simple measurements and lab testing.

Criteria for diagnosis

  • You have metabolic syndrome if you meet three or more of the following criteria:
  • Waist circumference >40 inches (men), 35 inches (women) indicates abdominal obesity.
  • ≥150 mg/dL or on medication for excessive triglycerides.
  • Low HDL cholesterol: <40 mg/dL (men), <50 mg/dL (women), or on medication.
  • Blood pressure (BP): ≥130/85 mmHg or the patient is on hypertension medication.
  • High fasting blood sugar: ≥100 mg/dL or taking diabetes medication.

How Doctors Check

  • A waist measurement and blood pressure screening.
  • Blood tests: Triglycerides, HDL cholesterol, and fasting glucose.
  • Medical history: Blood pressure, cholesterol, and diabetic medicines.

Early metabolic syndrome symptoms

The first indicators of metabolic syndrome are frequently modest. It's often discovered during basic health examinations. Daily clues may indicate the problem is developing.

Early Warning Signs

  • Abdominal obesity: Waist size increases, especially belly fat.
  • Acanthosis nigricans causes dark, velvety patches on the neck, armpits, or groin due to insulin resistance.
  • More thirst and urination: High blood sugar.
  • Early sign of elevated glucose: blurred eyesight.
  • Fatigue: Poor glucose utilization causes low energy.
  • Symptoms of high blood pressure include headaches, dizziness, and occasional nosebleeds.

Why They Matter

These symptoms indicate insulin resistance, hypertension, and high cholesterol, which increase the risk of type 2 diabetes, heart disease, and stroke.

Long-term metabolic syndrome hazards

Major Long-Term Risks

  • Type 2 diabetes: Insulin resistance causes kidney, nerve, and visual impairment.
  • Heart disease: Atherosclerosis increases the risk of heart attack and angina.
  • Clotting and brain vascular damage worsen with high blood pressure and cholesterol.
  • Cirrhosis and liver failure can result from non-alcoholic fatty liver disease (NAFLD).
  • Dialysis may be needed for chronic renal disease caused by hypertension and diabetes.
  • OSA: Obesity promotes airway collapse, causing weariness and heart strain.
  • Chronic inflammation and hormonal changes increase colon, breast, and liver cancer risk.

Preventing metabolic syndrome consequences

Preventing metabolic syndrome problems requires lifestyle adjustments to address obesity, insulin resistance, high blood pressure, and abnormal cholesterol. These steps greatly lower diabetes, heart disease, and stroke risk.

Lebensstrategien

  • Healthy diet: Eat fruits, vegetables, whole grains, lean proteins, and healthy fats like the Mediterranean or DASH diet. Cut back on processed meals, sugar, and refined carbs.
  • Even a 5–10% weight loss lowers blood sugar, blood pressure, and cholesterol.
  • For regular exercise, aim for 150 minutes of moderate aerobic activity per week and strength training twice a week.
  • Quitting smoking improves insulin sensitivity and cardiovascular risk.
  • Drinking too much raises blood pressure and triglycerides.
  • Stress management: Yoga, meditation, and deep breathing decrease cortisol and enhance metabolism.
  • Healthy sleep: 7–9 hours a night decreases insulin resistance and hormone imbalance.

The Medical Support

  • Blood pressure drugs: When lifestyle improvements fail.
  • The statins regulate cholesterol.
  • Metformin: Controls insulin-resistant blood sugar.
  • In severe obesity, bariatric surgery is considered when other methods fail.

Who Risks?

  • Especially central (belly) obesity.
  • Patients with prediabetes or type 2 diabetes often have insulin resistance.
  • Age: Risk rises after 40.
  • Sedentary lifestyle: Inactivity increases weight and insulin resistance.
  • Consumption of refined carbs, sugar, and processed foods is unhealthy.
  • Family history: Genetics affect diabetes and hypertension.
  • Hispanics, South Asians, and African Americans have higher prevalence.
  • Hormonal conditions: PCOS raises women's risk.
  • Smoking raises cholesterol and blood pressure.

Medical metabolic syndrome monitoring tests

  • Core Monitoring Tests
  • The waist circumference measures central obesity.
  • Blood pressure: Hypertension detection.
  • Fasting blood glucose: Detecting prediabetes and diabetes.
  • Tests triglycerides and HDL cholesterol.
  • The HbA1c test tracks blood sugar over time.

Extra Monitoring

  • Oral glucose tolerance test: Shows glucose metabolism issues.
  • Fatty liver disease screening by liver function tests.
  • Diabetic nephropathy and kidney function testing.
  • ECG: Detects hypertension and diabetes-related cardiac rhythm issues.
  • Sleep tests: For apnea.
The video explains what metabolic syndrome is in detail



Metabolic syndrome treatment

Metabolic syndrome is treated through lifestyle changes and medications that reduce obesity, high blood pressure, high blood sugar, and abnormal cholesterol. Prevention of diabetes, heart disease, and stroke is the goal.

First-Line Treatment: Lifestyle Changes

  • Heart-healthy Mediterranean or DASH diet: vegetables, fruits, whole grains, lean meats, and healthy fats. Sugar, salt, alcohol, and processed foods should be limited.
  • Regular exercise: 30 minutes of brisk walking or other activities most days. Exercise decreases blood pressure and increases insulin sensitivity without weight loss.
  • Weight loss: Up to 58% lower type 2 diabetes risk with 5–10% weight loss.
  • Quit smoking: Lowers cardiovascular risk and raises HDL cholesterol.
  • Stress management: Yoga, meditation, and mindfulness diminish cortisol, which boosts blood sugar and lipids.
  • Less than 7–9 hours of sleep affects insulin resistance and blood pressure.

If lifestyle doesn't work, medications

  • Diuretics, beta-blockers, ACE inhibitors, and ARBs.
  • Statins and fibrates reduce LDL and triglycerides and raise HDL.
  • Metformin improves insulin sensitivity and is widely given for diabetes.
  • GLP-1 agonists (semaglutide, tirzepatide) may help you lose weight.

Advanced Choices

  • Bariatric surgery: For severe obesity when lifestyle and drugs fail.
  • Sleep apnea treatment: CPAP improves metabolism.

Risks and Factors

  • Diuretics may cause diabetes.
  • Surgery is risky and reserved for emergencies.
  • Lifestyle changes are permanent—short-term remedies fail.
  • Medical supervision is needed to safely customize treatment.

Conclusion:

Metabolic syndrome is a warning sign that several systems are under pressure and a chance to act early with lifestyle and medical care to protect long-term health.

These early symptoms may indicate metabolic syndrome, which generally develops silently. Regular blood pressure, glucose, cholesterol, and waist size tests are the best method to detect it early.


Prevention guidelines for early-onset colorectal cancer

Prevention guidelines for early-onset colorectal cancer

Overview of Early-onset Colorectal Cancer

The second most common cause of cancer-related fatalities and the third most common cancer globally is colorectal cancer. Usually, it begins as little polyps in the colon or rectum that, if left untreated, can develop into cancer. Early identification through screening significantly increases survival rates.

Colorectal Cancer: What Is It?

  • Definition: An unchecked proliferation of aberrant cells in the rectum or colon, two sections of the large intestine.
  • Origin: Usually starts out as benign polyps that, if neglected, can develop into cancer.
  • Global Burden: In 2022, it was responsible for over 900,000 deaths worldwide and around 10% of all cancer diagnoses.
Colorectal cancer

Symptoms

  • Alterations in bowel habits (constipation, diarrhoea, stool narrowing).
  • Stool containing blood (bright red or tar-like).
  • Bloating, cramping, or persistent stomach pain.
  • Weariness and inexplicable weight loss.
  • Chronic bleeding-related iron deficiency anaemia.

Screening and Diagnosis

  • Polyps are found and removed by colonoscopy and sigmoidoscopy.
  • Imaging: ultrasonography, CT, and MRI.
  • Biopsy: Verifies the type of malignancy.
  • Genetic testing: finds mutations that direct therapy.
  • Screening Programs: Frequent colonoscopies lower mortality and incidence.

Preventive

  • Consume a diet high in whole grains, fruits, and vegetables.
  • Limit alcohol and red and processed meats.
  • Keep up an active lifestyle and a healthy weight.
  • Don't smoke.
  • Get tested regularly after age 45 to 50, or earlier if you are at high risk.

Risk factors for colorectal cancer

Age (the majority of cases occur after 50), family history, inherited genetic disorders, inflammatory bowel disease, and lifestyle factors like alcoholism, smoking, obesity, and diets heavy in red and processed meats are the main risk factors for colorectal cancer. In India, screening and awareness are particularly crucial due to the increasing incidence among younger adults.

Important Risk Elements

  • Personal and Genetic History
  • Adenomatous polyps or colorectal cancer run in the family.
  • Inherited syndromes include Lynch syndrome (HNPCC) and familial adenomatous polyposis (FAP).
  • Recurrence risk is increased by a personal history of colorectal cancer or polyps.
  • Inflammatory bowel diseases include Crohn's and ulcerative colitis.
  • radiation exposure to the pelvis and abdomen during previous cancer treatments.

Lifestyle Elements

  • Diet: poor in fruits and vegetables, high in red and processed meats, and poor in vitamin D.
  • Men are more strongly linked to obesity, which is likewise linked to negative outcomes.
  • Physical inactivity: Living a sedentary lifestyle increases the risk.
  • Smoking: Long-term tobacco use raises the risk of cancer and polyps.
  • Alcohol: Higher risk is associated with moderate to excessive consumption.

Health Issues

  • Insulin resistance increases the likelihood of developing type 2 diabetes.
  • Cholecystectomy (gallbladder removal): There is a slightly increased risk of right-sided colon cancer.

Factors related to demographics

  • Age: People over 45 account for 93% of cases.
  • Sex: Women are more likely to acquire right-sided colon cancer after menopause, but men have a greater fatality rate.
  • Ethnicity: International research indicates that American Indians, African Americans, and Ashkenazi Jews are more vulnerable.

Screening techniques for colorectal cancer

For average-risk individuals, colorectal cancer screening should begin at age 45; for those with a family history or genetic disorders, it should begin earlier. Although stool-based tests (FIT, gFOBT, stool DNA) and imaging methods (CT colonography, sigmoidoscopy) are also commonly employed, a colonoscopy every ten years is the most effective test.

Principal Screening Techniques

  • Tests Based on Stools
  • The guaiac fecal occult blood test (gFOBT) involves dietary restrictions in order to detect concealed blood in stool. completed once a year.
  • Faecal immunochemical test (FIT): No dietary limitations; uses antibodies to detect blood. completed once a year.
  • FIT-DNA (sDNA-FIT, such as Cologuard): Identifies DNA mutations in feces and blood. carried out every three years.

Tests of Direct Visualization

  • Polyps may be removed via a colonoscopy, which examines the whole colon. Every ten years is recommended.
  • Flexible sigmoidoscopy: Examines the lower colon and rectum. completed every five years or, with annual FIT, every ten years.
  • CT colonography, also known as virtual colonoscopy, uses CT imaging to view the colon. carried out every five years.

Rules

  • Adults at average risk: Begin at age 45.
  • High-risk conditions (IBD, FAP, Lynch syndrome, family history): Screen more frequently and begin earlier (usually between the ages of 20 and 40).
  • Ages 76–85: Depending on health status, screening is customized.

Early signs of colorectal cancer

Regular screening is essential since early signs of colorectal cancer are frequently mild or nonexistent. They can include anaemia-related fatigue, blood in the stool, abdominal pain, chronic changes in bowel habits, and unexplained weight loss. Awareness is particularly crucial due to an increase in instances among younger individuals.

Typical Early Symptoms

  • Constipation, diarrhea, or narrowing of the stool that lasts more than a few days are examples of changes in bowel habits.
  • Stools that include blood might be bright red, dark brown, or black. It's essential to pay attention to even the smallest amounts.
  • The feeling that the bowel does not empty after a movement is known as incomplete bowel emptying.
  • Persistent fullness, bloating, or pain are examples of abdominal pain or cramps.
  • Losing weight without dieting or altering one's lifestyle is known as "unexplained weight loss."
  • Weakness and exhaustion: Frequently brought on by concealed blood loss that results in iron-deficiency anemia.

The Significance of Early Detection

  • Screening is the most effective preventive measure because polyps and early malignancies frequently have no symptoms.
  • When doctors discover colorectal cancer early, survival rates exceed 90%, but they drop sharply once the cancer spreads.
  • Since late-stage diagnosis is typical, it's critical to spot minor symptoms and schedule an appointment for a colonoscopy or FIT tests as soon as possible.
The video explains how to prevent colorectal cancer

Techniques for treating colorectal cancer

Treatment plans for colorectal cancer are based on the patient's health, the tumour's location (colon vs. rectum), and its stage. While chemotherapy, radiation, targeted therapy, or immunotherapy frequently help manage advanced stages of the disease, surgery remains the mainstay for early stages. While late-stage therapy concentrates on control and quality of life, early identification enables curative treatment.

Treatment Strategies Based on Stages

Main Treatment Notes for Stage

  • Stage 0 (in situ): Local excision or polypectomy. Usually curative; no additional treatment is required.
  • Stage I: Surgery (proctectomy/colectomy). Frequently curative; adjuvant treatment is not necessary.
  • Stage II: Chemotherapy ± Surgery Rectum: radiation and chemotherapy before and following surgery; colon: chemotherapy in high-risk situations.
  • Stage III: Chemotherapy and surgery. Chemotherapy and radiation are used before and after surgery for rectal cancer.
  • Stage IV: Chemotherapy, targeted therapy, immunotherapy, and surgery. Palliative care is used to relieve symptoms; surgery may be used to remove lung or liver metastases.

Methods of Treatment

  • Surgery
  • primary treatment choice.
  • Types include abdominoperineal resection, colectomy, proctectomy, and polypectomy.
  • Colostomy may be necessary in cases of rectal cancer.

Chemotherapy

  • Medications such as irinotecan, oxaliplatin, capecitabine, and 5-FU.
  • Used as a neoadjuvant (before to surgery) or adjuvant (after surgery).

Radiation treatment

  • It is more typical in cases of rectal cancer.
  • Reduces tumor size before surgery or eliminates any remaining cells after surgery.

Targeted treatment for KRAS/NRAS wild-type cancers with EGFR inhibitors (cetuximab, panitumumab).

Bevacizumab, a VEGF inhibitor, is used to treat metastatic illness.

Immunotherapy

  • Pembrolizumab and nivolumab are checkpoint inhibitors for MSI-H/dMMR cancers.
  • Efficient in situations that are advanced or recurrent.

Treatment-related risks and considerations

  • Infection, bleeding, and gastrointestinal dysfunction are risks associated with surgery.
  • Chemotherapy side effects include tiredness, neuropathy, and nausea.
  • Radiation: May result in sexual dysfunction and intestinal discomfort.
  • Immunotherapy and targeted therapy may cause immunological adverse effects.

Conclusion

Although colorectal cancer is one of the most treatable and preventable tumors when caught early, it is nevertheless a significant worldwide health concern. Before becoming malignant, the disease usually starts as benign polyps that doctors can remove. Age, lifestyle choices, and heredity are risk factors. Screening techniques like colonoscopy or stool-based testing are crucial for prompt detection because early symptoms are frequently vague.

In conclusion, early detection and aggressive prevention are critical to the prognosis of colorectal cancer. The best strategy to lower risk and increase survival is to adopt healthy habits and talk to a gastroenterologist about timely screening.


Acquired TTP requires contemporary treatment.

Acquired TTP requires contemporary treatment. 

Acquired TTP-Outline

Autoantibodies against the ADAMTS13 (an enzyme in the blood that regulates clotting by cutting von Willebrand factor (vWF) into smaller, manageable pieces) cause acquired thrombotic thrombocytopenic purpura (aTTP), a rare and potentially fatal blood condition that leads to organ ischemia, severe thrombocytopenia, hemolytic anaemia, and extensive microvascular clots. Since contemporary treatment yields >95% recovery and untreated cases are >90% deadly, early detection and prompt plasma exchange therapy are crucial.

What is Acquired TTP?

  • Low platelets, microangiopathic hemolytic anaemia, and organ ischemia brought on by platelet-rich clots in tiny capillaries are the hallmarks of this thrombotic microangiopathy.
  • Cause: The enzyme ADAMTS13, which cleaves von Willebrand factor (VWF), is blocked by autoantibodies. Ultra-large VWF multimers cause aberrant coagulation in the absence of it.
  • Onset: Usually in maturity, though it can happen to kids as well.
  • Prevalence: around one new case per million per year; women are more likely to be affected.

Symptoms

  • Neurological: Personality changes, coma, headaches, seizures, and confusion.
  • Renal: Hematuria, acute renal damage.
  • Heart: Myocardial infarction, arrhythmias, and chest discomfort.
  • Abdominal pain, fever, purpura (skin bleeding spots), fatigue, and jaundice are all common.
  • Up to 60% of individuals experience relapses during abrupt episodes that last days to weeks.

Diagnosis

  • Blood smear: Broken red blood cells, or schistocytes.
  • Lab tests include diminished haptoglobin, increased LDH, indirect bilirubin, and severe thrombocytopenia.
  • Key marker: acquired TTP is confirmed by ADAMTS13 activity <10% with autoantibodies.
  • Before confirmatory testing, the PLASMI helps estimate the likelihood.

Therapy

  • First-line: Daily plasma exchange (PEX) to provide ADAMTS13 and eliminate autoantibodies.
  • Adjuncts
  • Immunosuppressive glucocorticoids
  • Rituximab (monoclonal antibody against CD20)
  • The anti-VWF nanobody caplacizumab decreases the production of clots.
  • Cyclosporine A, vincristine, cyclophosphamide, or splenectomy are examples of refractory patients.
  • Prognosis: Over 95% of patients recover with treatment; over 90% die without it.

Hazards and Things to Think About

  • Long-term follow-up is required, and relapse monitoring is crucial.
  • Pregnancy can trigger episodes that resemble preeclampsia.
  • Complications include heart failure, kidney failure, and brain injury.
  • Delays raise the danger of death; early plasma exchange is life-saving.

Acquired TTP diagnosis

A combination of blood tests, clinical suspicion, and confirmation of significantly decreased ADAMTS13 enzyme activity (<10%) plus autoantibodies is used to diagnose acquired thrombotic thrombocytopenic purpura (aTTP). Since aTTP represents a medical emergency, a quick diagnosis is required, frequently employing scoring systems like PLASMIC before confirmatory assays are available.

Crucial Diagnostic Procedures

Clinical suspicion

  • Fever, neurological symptoms (seizures, disorientation), microangiopathic hemolytic anemia, thrombocytopenia, and renal failure all occur suddenly.

Smear of blood:

  • One characteristic observation is the presence of schistocytes, or broken red blood cells.

CBC, or complete blood count:

  • Exhibits significant anemia and thrombocytopenia.

Labs for hemolysis:

  • Increased LDH
  • High levels of indirect bilirubin
  • Diminished haptoglobin
  • A negative Coombs test can be used to differentiate autoimmune hemolytic anemia.

Assay for ADAMTS13 activity:

  • TTP is highly supported by activity <10%.
  • Anti-ADAMTS13 autoantibody detection verifies acquired TTP.

Tests for kidney function:

  • Hematuria, proteinuria, or elevated creatinine.

PLASMIC rating:

  • Before laboratory confirmation, the likelihood of a severe ADAMTS13 deficit is estimated using a clinical grading system.

Clinical Aspects

  • Quick diagnosis is essential because untreated aTTP has a death rate of over 90%.
  • If suspicions are high, do not postpone plasma exchange while waiting for ADAMTS13 results.
  • Distinguish it from other thrombotic microangiopathies, such as malignant hypertension, DIC, and HUS.
The video about Caplacizumab combination therapy for Acquired TTP


Treatment for acquired TTP

Treatment for acquired thrombotic thrombocytopenic purpura (aTTP) requires immunosuppression and rapid plasma exchange. When begun immediately, modern regimens frequently include rituximab to prevent recurrence and caplacizumab to minimize clot formation, with survival rates exceeding 90%.

First-Line Treatment

Exchange of plasma (PEX):

  • Patient plasma is removed every day and replaced with donor plasma.
  • Eliminates autoantibodies against ADAMTS13.
  • provides an active ADAMTS13 enzyme.
  • Lifesaving: with treatment, mortality decreases from over 90% to less than 10%.

Glucocorticoids:

  • High-dose steroids decrease inflammation and immune-mediated antibody formation.

Modern and Adjunctive Therapies

  • Caplacizumab
  • nanobody against von Willebrand factor.
  • decreases early relapses, accelerates platelet healing, and prevents platelet clumping.
  • It is used in addition to steroids and plasma exchange.

Rituximab

  • Monoclonal antibody against CD20.
  • Targets B lymphocytes that make antibodies against ADAMTS13.
  • It is efficient in achieving long-lasting remission and preventing relapses.

Additional immunosuppressants (in those who are resistant):

  • Cyclophosphamide
  • Vincristine
  • Cyclosporine A
  • Splenectomy (uncommon, last option).

New and Investigative Choices

For congenital TTP, recombinant ADAMTS13 has already received FDA approval; trials for acquired TTP are still in progress.

Treatments based on plasma cells:

  • Bortezomib
  • Daratumumab
  • Try to eradicate plasma cells that produce antibodies.
  • Long-term correction through gene therapy is being investigated.

Hazards and Things to Think About

  • Relapse risk: up to 60% of patients; ADAMTS13 activity must be continuously monitored.
  • Pregnancy: May cause episodes; must be handled carefully.
  • Complications include kidney failure, neurological damage, and cardiac events if treatment is postponed.

Preventing relapses in acquired TTP

In acquired thrombotic thrombocytopenic purpura (aTTP), lifestyle awareness, early immunosuppressive treatment, and long-term monitoring of ADAMTS13 activity are the main strategies for preventing relapses. Proactive measures are crucial because up to 60% of patients relapse.

Medical Techniques

  • ADAMTS13 surveillance
  • Testing should be done regularly (every three to six months) to identify decreasing enzyme activity.
  • Preventive therapy is possible since declining levels frequently occur before clinical recurrence.
  • Rituximab upkeep
  • Anti-CD20 monoclonal antibody decreases B-cell-mediated autoantibody synthesis.Used as a preventative measure in patients whose ADAMTS13 activity is consistently low.

Caplacizumab 

  • It stops platelets from clumping together during acute bouts.
  • Although long-term use is debatable, there is an emerging function in lowering early relapses.
  • In refractory cases, further immunosuppressants such as mycophenolate, cyclophosphamide, or cyclosporine A may be administered.

Clinical Monitoring

  • Frequent visits to the haematologist
  • Periodically, renal function, bilirubin, LDH, and CBC are measured.
  • heart and neurological evaluations for minor organ damage.
  • Monitoring throughout pregnancy
  • Obstetrics and haematology must work closely together because pregnancy is a proven trigger.

Lifestyle & Helpful Actions

  • Stress reduction
  • Relapse triggers can be lessened through yoga, meditation, and relaxation practices.
  • Steer clear of triggers.
  • Specific drugs, surgery, and infections can trigger relapse.
  • Infection management and vaccinations are crucial preventative measures.
  • Patient education
  • identifying early warning indicators (confusion, bruises, and exhaustion).
  • Prompt medical attention if symptoms return.

Is there a treatment for thrombotic thrombocytopenic purpura?

Although disease is very treatable, thrombotic thrombocytopenic purpura (TTP) is not thought to be "curable" in the long run. Over 90% of patients survive with immediate plasma exchange and immunosuppressive treatment, and many experience long-term remission. Relapses are frequent, though; therefore, preventive care and continuous observation are crucial.

Important Curability Facts

  • Mortality rises over 90–95% in the absence of treatment.
  • 80–90% of individuals had improved survival with treatment.
  • Risk of relapse: Recurrence is possible in up to 60% of acquired TTP patients.
  • Congenital TTP: Recombinant ADAMTS13 or plasma infusion is used to treat it; lifetime treatment is necessary.
  • Acquired TTP: Treated with plasma exchange, prednisone, rituximab, and caplacizumab; relapses require attention, but remission is achievable.

Why It's Not "Curable"

  • The underlying cause is still present:
  • Autoantibodies against ADAMTS13 may resurface in acquired TTP.
  • Genetic abnormalities in congenital TTP permanently reduce the synthesis of ADAMTS13.
  • Relapse potential: Patients are still susceptible to flare-ups brought on by stress, pregnancy, or infections, even after remission.
  • Chronic management: Needs routine ADAMTS13 activity monitoring, long-term hematologist follow-up, and occasionally preventative rituximab therapy.

Results of Treatment

  • Type of TTP Treatment Result
  • Acquired TTP: steroids + rituximab/caplacizumab + plasma exchange. High rates of remission, potential for return
  • Congenital TTP: Recombinant ADAMTS13 or plasma infusion. Long-term treatment and steady control
  • Untreated TTP: No treatment. >90% of deaths

Conclusion

Although there is no permanent cure for TTP, it is very controllable. As long as they get routine monitoring and relapse prevention techniques, the majority of patients with contemporary therapies survive and lead normal lives.